International Parkinson and Movement Disorder Society

International Parkinson and Movement Disorder Society The International Parkinson and Movement Disorder Society (MDS) is a professional society of clinicians, scientists, and other healthcare professionals.

MDS is a professional society of clinicians, scientists, and other healthcare professionals, who are interested in Parkinson's disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic Movement Disorders, and abnormalities in muscle tone and motor control. The spectrum of clinical disorders represented by the Society includes but is not limited to:

* Parkinson's disease an

d parkinsonism
* Dystonia
* Chorea, Huntington's disease
* Ataxia
* Tremor and essential tremor
* Myoclonus and startle
* Tics and Tourette syndrome
* Restless legs syndrome
* Stiff person syndrome
* Gait disorders

The objective and mission of the Society shall be to advance the neurological sciences pertaining to Movement Disorders; to operate exclusively for scientific, scholarly and educational purposes; to encourage research; to provide forums, such as medical journals, scientific symposia and International Congresses, for sharing ideas and for advancing the related clinical and scientific disciplines; and to encourage interest and participation in the activities of the Society among healthcare and allied professionals and scientists; and to collaborate with other related professional and lay organizations. To view MDS' Social Media Policy, click on the link below:

http://www.movementdisorders.org/MDS/About/MDS-Policies/MDS-Social-Media-Policy.htm

Next-generation sequencing has advanced our understanding of epilepsy-dyskinesia syndromes, shifting diagnosis from symp...
07/24/2025

Next-generation sequencing has advanced our understanding of epilepsy-dyskinesia syndromes, shifting diagnosis from symptom-based categories to those defined by shared genetic and pathophysiological mechanisms.

07/23/2025

Human aging and brain cell degeneration go hand in hand due to prolonged protein aggregation. This panel discussion will explain how neurobiological mechanisms inform key therapeutic strategies. Mdscongress.org

Explore the latest in Parkinson’s disease research at the MDJ Symposium on November 14 in San Diego, CA, USA. A must-att...
07/22/2025

Explore the latest in Parkinson’s disease research at the MDJ Symposium on November 14 in San Diego, CA, USA. A must-attend satellite event of . Register now: https://loom.ly/1CJxmpY

This symposium is organized by the editorial team of Movement Disorders, the official journal of the International Parkinson and Movement Disorder Society. The symposium will explore the biological underpinnings of Parkinson’s disease (PD), the neurobiological basis for current and emerging treat...

07/22/2025

Call for: Photographs, letters, medical artifacts, books, and/or memorabilia that focus on Jean-Martin Charcot and the 19th century French neurological school for an exhibit at the 2025 International Congress in Honolulu.

Learn more and submit here: https://loom.ly/Q84HLyo

DBS presurgical evaluations often involve a multidisciplinary team, yet social workers are underutilized. Dr. Amanda Cur...
07/21/2025

DBS presurgical evaluations often involve a multidisciplinary team, yet social workers are underutilized. Dr. Amanda Currie shares insights on the value of social workers in the DBS process and how other programs may benefit from these findings. Nicole Duff Physiotherapist https://loom.ly/zrklMHE

07/21/2025

Clinical Clue from Dr. Abhimanyu Mahajan: Learn how to recognize mirror movements in early PD and how they may differ in corticobasal syndrome.

Levodopa has been the “gold standard” therapy for PD, but in recent years, therapy options have increased rapidly. These...
07/21/2025

Levodopa has been the “gold standard” therapy for PD, but in recent years, therapy options have increased rapidly. These options now include DBS, subcutaneous levodopa infusions, and various other pharmacological aids. Learn more: https://loom.ly/DsWX7_A

Young researcher highlight: The number of mitochondrial DNA copies within blood cells, or mtDNA-CN, could also function ...
07/20/2025

Young researcher highlight: The number of mitochondrial DNA copies within blood cells, or mtDNA-CN, could also function as a diagnostic biomarker for PD. https://loom.ly/EOj0ZwA

The number of mitochondrial DNA copies within blood cells, or mtDNA-CN, could also function as a diagnostic biomarker for PD.

“Double hit” of interactions between multiple pathologically affected circuits may predispose individuals to hallucinati...
07/17/2025

“Double hit” of interactions between multiple pathologically affected circuits may predispose individuals to hallucinating. https://loom.ly/8aXss_A

“Double hit” of interactions between multiple pathologically affected circuits may predispose individuals to hallucinating.

Join the new Cognition and Lewy Body Diseases Study Group to collaboratively study and advance research related to Lewy ...
07/16/2025

Join the new Cognition and Lewy Body Diseases Study Group to collaboratively study and advance research related to Lewy Body Diseases and Movement Disorders. Learn more: https://loom.ly/eiJ9MEE

Bring together experts from around the globe to collaboratively study and advance research related to Lewy Body Diseases and Movement Disorders.

Address

Milwaukee, WI

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Alerts

Be the first to know and let us send you an email when International Parkinson and Movement Disorder Society posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Our Story

MDS is a professional society of clinicians, scientists, and other healthcare professionals, who are interested in Parkinson's disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic Movement Disorders, and abnormalities in muscle tone and motor control. The spectrum of clinical disorders represented by the Society includes but is not limited to: * Parkinson's disease and parkinsonism * Dystonia * Chorea, Huntington's disease * Ataxia * Tremor and essential tremor * Myoclonus and startle * Tics and Tourette syndrome * Restless legs syndrome * Stiff person syndrome * Gait disorders The objective and mission of the Society shall be to advance the neurological sciences pertaining to Movement Disorders; to operate exclusively for scientific, scholarly and educational purposes; to encourage research; to provide forums, such as medical journals, scientific symposia and International Congresses, for sharing ideas and for advancing the related clinical and scientific disciplines; and to encourage interest and participation in the activities of the Society among healthcare and allied professionals and scientists; and to collaborate with other related professional and lay organizations. To view the MDS Social Media Policy, please visit: www.movementdisorders.org/social-media-policy